Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis

A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial

(2014) JA Michaels et al.   HEALTH TECHNOLOGY ASSESSMENT

Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis

(2013) Susan R. Kahn   ANNALS OF INTERNAL MEDICINE

Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis

(2013) Paolo Prandoni   ANNALS OF INTERNAL MEDICINE

Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism

(2013) Marc Carrier   ANNALS OF INTERNAL MEDICINE

Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation

(2013) James V. Freeman et al.   ANNALS OF INTERNAL MEDICINE

Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term

(2012) Paulien G. Jong et al.   BRITISH JOURNAL OF HAEMATOLOGY

Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review

(2012) Samantha MacLean et al.   CHEST

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Evidence-Based Management of Anticoagulant Therapy

(2012) Anne Holbrook et al.   CHEST

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors

(2012) Linda E. Flinterman et al.   PLOS MEDICINE

Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants

(2011) Paolo Prandoni   EUROPEAN JOURNAL OF HAEMATOLOGY

Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis

(2011) W. GHANIMA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation

(2011) R. GUANELLA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Catheter-directed thrombolysis for acute DVT

(2011) Lawrence V Hofmann et al.   LANCET

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

(2011) Tone Enden et al.   LANCET

Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis

(2010) Charlotte JJ van Asch et al.   LANCET NEUROLOGY

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency

(2009) T. ENDEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Getting intimate with the venous thrombus

(2009) S. SCHULMAN   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization

(2009) S. R. KAHN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

How Much Are Americans Willing to Pay for a Quality-Adjusted Life Year?

(2009) Milton C. Weinstein   MEDICAL CARE

Generation of a Danish TTO value set for EQ-5D health states

(2009) Kim U. Wittrup-Jensen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Three-Year Survival and Stroke Recurrence Rates in Patients With Primary Intracerebral Hemorrhage

(2009) Elisabet Zia et al.   STROKE

Determinants of health-related quality of life during the 2 years following deep vein thrombosis

(2008) S. R. KAHN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS